InterMune, Inc. (NASDAQ:ITMN)’s shares dropped 2.53% to $42.83. The company on July 3 announces that the U.S. Food and Drug Administration (the “FDA”) has acknowledged receipt...
StemCells Inc. (NASDAQ:STEM)’s shares declined 1.46% to $2.02. The company on July 7 announced the appointment of Alan Trounson, Ph.D. to its Board of Directors. Dr....
Amgen Inc. (NASDAQ:AMGN)’s shares declined 0.11% to $119.64. The company on July 1 announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy...
Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI)’s shares decreased 5.73% to $7.90. The company on July 7 announced that the U.S. Food and Drug Administration (FDA) has granted Accelerated...